The effects of baclofen for the treatment of gastroesophageal reflux disease: A meta-analysis of randomized controlled trials

Gastroenterology Research and Practice

Volumn 2014, Issue , 2014, Pages

  Li, Shujie ^a   Shi, Shengying ^a   Chen, Feng ^a   Lin, Jingming ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; PLACEBO; PROTON PUMP INHIBITOR;

ACCOMMODATION PARALYSIS; COCHRANE LIBRARY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EMBASE; FATIGUE; FLATULENCE; GASTROESOPHAGEAL REFLUX; HUMAN; INCIDENCE; INFORMATION RETRIEVAL; MEDLINE; META ANALYSIS; NAUSEA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCIENCEDIRECT; SOMNOLENCE; SYSTEMATIC REVIEW;

EID: 84911413426     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2014/307805     Document Type: Review

References (38)

1. Dent J., Kahrilas P. J., Vakil N., van Zanten S. V., Bytzer P., Delaney B., Haruma K., Hatlebakk J., Mccoll E., Moayyedi P., Stanghellini V., Tack J., Vaezi M., Clinical trial design in adult reflux disease: a methodological workshop. Alimentary Pharmacology and Therapeutics 2008 28 1 107 126 10.1111/j.1365-2036.2008.03700.x 2-s2.0-44649191123
2. Vakil N., van Zanten S. V., Kahrilas P., Dent J., Jones R., Bianchi L. K., Cesario K. B., The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. The American Journal of Gastroenterology 2006 101 8 1900 1920 10.1111/j.1572-0241.2006.00630.x 2-s2.0-33746709974
3. Vakil N. B., Huff F. J., Bian A., Jones D. S., Stamler D., Arbaclofen placarbil in GERD: a randomized, double-blind, placebo-controlled study. The American Journal of Gastroenterology 2011 106 8 1427 1438 10.1038/ajg.2011.121 2-s2.0-79961023673
4. Savarino E., Zentilin P., Tutuian R., Pohl D., Casa D. D., Frazzoni M., Cestari R., Savarino V., The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. The American Journal of Gastroenterology 2008 103 11 2685 2693 10.1111/j.1572-0241.2008.02119.x 2-s2.0-55349114697
5. Sarosiek J., McCallum R. W., Mechanisms of oesophageal mucosal defence. Bailliere's Best Practice and Research in Clinical Gastroenterology 2000 14 5 701 717 10.1053/bega.2000.0119 2-s2.0-0033793726
6. Sarosiek J., Scheurich C. J., Marcinkiewicz M., McCallum R. W., Enhancement of salivary esophagoprotection: rationale for a physiological approach to gastroesophageal reflux disease. Gastroenterology 1996 110 3 675 681 10.1053/gast.1996.v110.pm8608875 2-s2.0-0030067814
7. Chen D., Barber C., McLoughlin P., Thavaneswaran P., Jamieson G. G., Maddern G. J., Systematic review of endoscopic treatments for gastro-oesophageal reflux disease. The British Journal of Surgery 2009 96 2 128 136 10.1002/bjs.6440 2-s2.0-60049090830
8. Rohof W. O. A., Hirsch D. P., Boeckxstaens G. E. E., Pathophysiology and management of gastroesophageal reflux disease. Minerva Gastroenterologica e Dietologica 2009 55 3 289 300 2-s2.0-75749139774
9. Stedman C. A. M., Barclay M. L., Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Alimentary Pharmacology and Therapeutics 2000 14 8 963 978 10.1046/j.1365-2036.2000.00788.x 2-s2.0-0033859564
10. Brimblecombe R. W., Duncan W. A. M., Durant G. J., Emmett J. C., Ganellin C. R., Leslie G. B., Parsons M. E., Characterization and development of cimetidine as a histamine H2-receptor antagonist. Gastroenterology 1978 74 2, part 2 339 347 2-s2.0-0017811292
11. Fass R., Shapiro M., Dekel R., Sewell J., Systematic review: Proton-pump inhibitor failure in gastro-oesophageal reflux disease-where next? Alimentary Pharmacology and Therapeutics 2005 22 2 79 94 10.1111/j.1365-2036.2005.02531.x 2-s2.0-22844451154
12. Beaumont H., Boeckxstaens G. E. E., Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy. The American Journal of Gastroenterology 2009 104 7 1764 1771 10.1038/ajg.2009.247 2-s2.0-67650461959
13. Cange L., Johnsson E., Rydholm H., Lehmann A., Finizia C., Lundell L., Ruth M., Baclofen-mediated gastro-oesophageal acid reflux control in patients with established reflux disease. Alimentary Pharmacology and Therapeutics 2002 16 5 869 873 10.1046/j.1365-2036.2002.01250.x 2-s2.0-0036240152
14. Ciccaglione A. F., Marzio L., Effect of acute and chronic administration of the GABAB agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease. Gut 2003 52 4 464 470 10.1136/gut.52.4.464 2-s2.0-0242500869
15. Cossentino M. J., Mann K., Armbruster S. P., Lake J. M., Maydonovitch C., Wong R. K. H., Randomised clinical trial: The effect of baclofen in patients with gastro-oesophageal reflux-a randomised prospective study. Alimentary Pharmacology & Therapeutics 2012 35 9 1036 1044 10.1111/j.1365-2036.2012.05068.x 2-s2.0-84875706659
16. Gerson L. B., Huff F. J., Hila A., Hirota W. K., Reilley S., Agrawal A., Lal R., Luo W., Castell D., Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease. The American Journal of Gastroenterology 2010 105 6 1266 1275 10.1038/ajg.2009.718 2-s2.0-77953232099
17. Grossi L., Spezzaferro M., Sacco L. F., Marzio L., Effect of baclofen on oesophageal motility and transient lower oesophageal sphincter relaxations in GORD patients: a 48-h manometric study. Neurogastroenterology and Motility 2008 20 7 760 766 10.1111/j.1365-2982.2008.01115.x 2-s2.0-44949257972
18. B agonist baclofen in normal subjects. Gastroenterology 2000 118 1 7 13 10.1016/S0016-5085(00)70408-2 2-s2.0-0033958395
19. Omari T. I., Benninga M. A., Sansom L., Butler R. N., Dent J., Davidson G. P., Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: a randomized controlled trial. The Journal of Pediatrics 2006 149 4 474 468 10.1016/j.jpeds.2006.05.029 2-s2.0-33748977207
20. van Herwaarden M. A., Samsom M., Rydholm H., Smout A. J. P. M., The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease. Alimentary Pharmacology and Therapeutics 2002 16 9 1655 1662 10.1046/j.1365-2036.2002.01325.x 2-s2.0-0036735045
21. Xu Q., Pan J., Yu J., Liu X., Liu L., Zuo X., Wu P., Deng H., Zhang J., Ji A., Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy. Diabetes Research and Clinical Practice 2013 101 2 99 105 10.1016/j.diabres.2013.03.033 2-s2.0-84881263911
22. Mu Y. P., Liu R. L., Wang L. Q., Deng X., Zhu N., Wei M. D., Wang Y., Moxifloxacin monotherapy for treatment of complicated intra-abdominal infections: a meta-analysis of randomised controlled trials. International Journal of Clinical Practice 2012 66 2 210 217 10.1111/j.1742-1241.2011.02839.x 2-s2.0-84862918972
23. Moher D., Liberati A., Tetzlaff J., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine 2009 151 4 264 269
24. Moher D., Jadad A. R., Tugwell P., Assessing the quality of randomized controlled trials: current issues and future directions. International Journal of Technology Assessment in Health Care 1996 12 2 195 208 10.1017/S0266462300009570 2-s2.0-0029889927
25. Moher D., Pham B., Jones A., Cook D. J., Jadad A. R., Moher M., Tugwell P., Klassen T. P., Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? The Lancet 1998 352 9128 609 613 10.1016/S0140-6736(98)01085-X 2-s2.0-0032558314
26. Olivo S. A., Macedo L. G., Gadotti I. C., Fuentes J., Stanton T., Magee D. J., Scales to assess the quality of randomized controlled trials: a systematic review. Physical Therapy 2008 88 2 156 175 10.2522/ptj.20070147 2-s2.0-38949096718
27. Xenodemetropoulos T., Khan K. J., Leontiadis G. I., Armstrong D., Moayyedi P., W1096 the gamma-aminobutyric acid (GABA) receptor agonist baclofen in the treatment of gastroesophageal reflux disease (GERD): a systematic review. Gastroenterology 2010 138 5 supplement 1 S 650 10.1016/S0016-5085(10)62994-0
28. Mainie I., Tutuian R., Shay S., Vela M., Zhang X., Sifrim D., Castell D. O., Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006 55 10 1398 1402 10.1136/gut.2005.087668 2-s2.0-33745789780
29. Vela M. F., Tutuian R., Katz P. O., Castell D. O., Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Alimentary Pharmacology and Therapeutics 2003 17 2 243 251 10.1046/j.1365-2036.2003.01394.x 2-s2.0-0347708695
30. Koek G. H., Sifrim D., Lerut T., Janssens J., Tack J., Effect of the GABAB agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut 2003 52 10 1397 1402 10.1136/gut.52.10.1397 2-s2.0-0141757445
31. Zhang Q., Lehmann A., Rigda R., Dent J., Holloway R. H., Control of transient lower oesophageal sphincter relaxations and reflux by the GABAB agonist baclofen in patients with gastro-oesophageal reflux disease. Gut 2002 50 1 19 24 10.1136/gut.0500019. 2-s2.0-0036136088
32. Sachs G., Shin J. M., Hunt R., Novel approaches to inhibition of gastric acid secretion. Current Gastroenterology Reports 2010 12 6 437 447 10.1007/s11894-010-0149-5 2-s2.0-78649908709
33. Peghini P. L., Katz P. O., Bracy N. A., Castell D. O., Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. American Journal of Gastroenterology 1998 93 5 763 767 10.1111/j.1572-0241.1998.221-a.x 2-s2.0-0032081150
34. Sachs G., Proton pump inhibitors and acid-related diseases. Pharmacotherapy 1997 17 1 22 37 2-s2.0-0031017338
35. Grossi L., Ciccaglione A. F., Travaglini N., Marzio L., Transient lower esophageal sphincter relaxations and gastroesophageal reflux episodes in healthy subjects and GERD patients during 24 hours. Digestive Diseases and Sciences 2001 46 4 815 821 10.1023/A:1010708602777 2-s2.0-0035027379
36. Orlando R. C., Overview of the mechanisms of gastroesophageal reflux. The American Journal of Medicine 2001 111 supplement 8A 174S 177S
37. Boeckxstaens G. E. E., Review article: the pathophysiology of gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 2007 26 2 149 160 10.1111/j.1365-2036.2007.03372.x 2-s2.0-34250826458
38. Orr W. C., Goodrich S., Wright S., Shepherd K., Mellow M., The effect of baclofen on nocturnal gastroesophageal reflux and measures of sleep quality: a randomized, cross-over trial. Neurogastroenterology and Motility 2012 24 6 553.e253 559.e253 10.1111/j.1365-2982.2012.01900.x 2-s2.0-84861194666